Beta-adrenergic signals regulate adipogenesis of mouse mesenchymal stem cells via cAMP/PKA pathway

Molecular and Cellular Endocrinology

Volumn 323, Issue 2, 2010, Pages 201-207

  Li, Haifang ^a,b   Fong, Chichun ^b   Chen, Yao ^b   Cai, Guoping ^a   Yang, Mengsu ^b  

^a TSINGHUA UNIVERSITY   (China)

^b CITY UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Adipogenesis; CAMP PKA pathway; Mesenchymal stem cells (MSCs); Adrenergic receptors ( ARs)

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BETA 3 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; MESSENGER RNA; ISOPRENALINE;

ADIPOGENESIS; ANIMAL CELL; ARTICLE; BETA ADRENERGIC STIMULATION; BONE MARROW; CELL DIFFERENTIATION; CONTROLLED STUDY; GENE EXPRESSION REGULATION; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; ADIPOCYTE; ANIMAL; CELL CULTURE; CYTOLOGY; DOSE RESPONSE; DRUG EFFECTS; FEMALE; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

ADIPOCYTES; ADIPOGENESIS; ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; ISOPROTERENOL; MESENCHYMAL STROMAL CELLS; MICE; RECEPTORS, ADRENERGIC, BETA-2; RECEPTORS, ADRENERGIC, BETA-3; SIGNAL TRANSDUCTION;

EID: 77952959580     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2010.03.021     Document Type: Article

References (41)

1. Antras J., Lasnier F., Pairault J. β-Adrenergic-cyclic AMP signalling pathway modulates cell function at the transcriptional level in 3T3-F442A adipocytes. Mol. Cell. Endocrinol. 1991, 82:183-190.
2. Atgié C., Faintrenie G., Carpéné C., Bukowiecki L.J., Géloën A. Effects of chronic treatment with noradrenaline or a specific β3-adrenergic agonist, CL 316,243, on energy expenditure and epididymal adipocyte lipolytic activity in rat. Comp. Biochem. Physiol. A 1998, 119:629-636.
3. Bachman E.S., Dhillon H., Zhang C.Y., Cinti S., Bianco A.C., Kobilka B.K., Lowell B.B. βAR signaling required for diet-induced thermogenesis and obesity resistance. Science 2002, 297:843-845.
4. Benovic J.L., Bouvier M., Caron M.G., Lefkowitz R.J. Regulation of adenylyl cyclase-coupled beta-adrenergic receptors. Annu. Rev. Cell Biol. 1988, 4:405-428.
5. Canová N.K., Lincová D., Kmoníbková E., Kameníková L., Farghali H. Nitric oxide production from rat adipocytes is modulated by β3-adrenergic receptor agonists and is involved in a cyclic AMP-dependent lipolysis in adipocytes. Nitric Oxide 2006, 14:200-211.
6. Dennis J.E., Merriam A., Awadallah A., Yoo J.U., Johnstone B., Caplan A.I. A quadripotential mesenchymal progenitor cell isolated from the marrow of an adult mouse. J. Bone Miner. Res. 1999, 14:700-709.
7. De Ugarte D.A., Morizono K., Elbarbary A., Alfonso Z., Zuk P.A., Zhu M., Dragoo J.L., Ashjian P., Thomas B., Benhaim P., Chen I., Fraser J., Hedrick M.H. Comparison of multi-lineage cells from human adipose tissue and bone marrow. Cells Tissues Organs 2003, 174:101-109.
8. S-protein-coupled pathway in 3T3-L1 adipocytes. FEBS Lett. 2001, 500:60-63.
9. Fasshauer M., Klein J., Neumann S., Eszlinger M., Paschke R. Adiponectin gene expression is inhibited by β-adrenergic stimulation via protein kinase A in 3T3-L1 adipocytes. FEBS Lett. 2001, 507:142-146.
10. Fève B., Emorine L.J., Lasnier F., Blin N., Baude B., Nahmias C., Strosberg A.D., Pairault J. Atypical β-adrenergic receptor in 3T3-F442A adipocytes. Pharmacological and molecular relationship with the human β3-adrenergic receptor. J. Biol. Chem. 1991, 266:20329-20336.
11. Fukumoto T., Sperling J.W., Sanyal A., Fitzsimmons J.S., Reinholz G.G., Conover C.A., O'Driscoll S.W. Combined effects of insulin-like growth factor-1 and transforming growth factor-beta1 on periosteal mesenchymal cells during chondrogenesis in vitro. Osteoarthr. Cartilage 2003, 11:55-64.
12. Germack R., Starzec A.B., Vassy R., Perret G.Y. β-Adrenoceptor subtype expression and function in rat white adipocytes. Brit. J. Pharmacol. 1997, 120:201-210.
13. Guest S.J., Hadcock J.R., Watkins D.C., Malbon C.C. β1- and β2-adrenergic receptor expression in differentiating 3T3-Ll cells. J. Biol. Chem. 1990, 265:5370-5375.
14. Hadri K.E., Fève B., Pairault J. Developmental expression and functional activity of β1- and β3-adrenoceptors in murine 3T3-F442A differentiating adipocytes. Eur. J. Pharmacol. 1996, 297:107-119.
15. Haskó G., Szabó C. Regulation of cytokine and chemokine production by transmitters and co-transmitters of the autonomic nervous system. Biochem. Pharmacol. 1998, 56:1079-1087.
16. Hotamisligil G.S., Shargill N.S., Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity linked insulin resistance. Science 1993, 259:87-91.
17. Jankowski R.J., Deasy B.M., Huard J. Muscle-derived stem cells. Gene Ther. 2002, 9:642-647.
18. Kershaw E.E., Hamm J.K., Verhagen L.A.W., Peroni O., Katic M., Flier J.S. Adipose triglyceride lipase. Function, regulation by insulin, and comparison with adiponutrin. Diabetes 2006, 55:148-157.
19. Kim H.B., Kim W.H., Han K.L., Park J.H., Lee J., Yeo J., Jung M.H. cAMP-response element binding protein (CREB) positively regulates mouse adiponectin gene expression in 3T3-L1 adipocytes. Biochem. Biophys. Res. Commun. 2010, 391:634-639.
20. Klaus S., Seivert A., Boeuf S. Effect of the β3-adrenergic agonist Cl316,243 on functional differentiation of white and brown adipocytes in primary cell culture. Biochim. Biophys. Acta 2001, 1539:85-92.
21. Klemm D.J., Leitner J.W., Watson P., Nesterova A., Reusch J.E., Goalstone M.L., Draznin B. Insulin-induced adipocyte differentiation. Activation of CREB rescues adipogenesis from the arrest caused by inhibition of prenylation. J. Biol. Chem. 2001, 276:28430-28435.
22. Koo K.H., Dussault R., Kaplan P., Kim R., Ahn I.O., Christopher J., Song H.R., Wang G.J. Age-related marrow conversion in the proximal metaphysis of the femur: evaluation with T1-weighted MR imaging. Radiology 1998, 206:745-748.
23. Li X., Cui Q., Kao C., Wang G.J., Balian G. Lovastatin inhibits adipogenic and stimulates osteogenic differentiation by suppressing PPARγ2 and increasing Cbfa1/Runx2 expression in bone marrow mesenchymal cell cultures. Bone 2003, 33:652-659.
24. Lindgren E.M., Nielsen R., Petrovic N., Jacobsson A., Mandrup S., Cannon B., Nedergaard J. Noradrenaline represses PPAR (peroxisome-proliferator-activated receptor) γ 2 gene expression in brown adipocytes: intracellular signalling and effects on PPARγ 2 and PPARγ 1 protein levels. Biochem. J. 2004, 382:597-606.
25. Margareto J., Larrarte E., Marti A., Martinez J.A. Up-regulation of a thermogenesis-related gene (UCP1) and downregulation of PPARγ and aP2 genes in adipose tissue: possible features of the antiobesity effects of a β3-adrenergic agonist. Biochem. Pharmacol. 2001, 61:1471-1478.
26. Meunier P., Aaron J., Edouard C., Vignon G. Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies. Clin. Orthop. Relat. Res. 1971, 80:147-154.
27. Miura M., Gronthos S., Zhao M., Lu B., Fisher L.W., Robey P.G., Shi S. SHED: stem cells from human exfoliated deciduous teeth. PNAS 2003, 100:5807-5812.
28. Noël D., Caton D., Roche S., Bony C., Lehmann S., Casteilla L., Jorgensen C., Cousin B. Cell specific differences between human adipose-derived and mesenchymal-stromal cells despite similar differentiation potentials. Exp. Cell Res. 2008, 314:1575-1584.
29. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000, 43:533-549.
30. Nuttall M.E., Gimble J.M. Is there a therapeutic opportunity to either prevent or treat osteopenic disorders by inhibiting marrow adipogenesis?. Bone 2000, 27:177-184.
31. Pei L., Tontonoz P. Fat's loss is bone's gain. J. Clin. Invest. 2004, 113:805-806.
32. Prockop D.J. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74.
33. Rehnmark S., Antonson P., Xanthopoulos K.G., Jacobsson A. Differential adrenergic regulation of C/EBPα and C/EBPβ in brown adipose tissue. FEBS Lett. 1993, 318:235-241.
34. Reusch J.E., Colton L.A., Klemm D.J. CREB activation induces adipogenesis in 3T3-L1 cells. Mol. Cell. Biol. 2000, 20:1008-1020.
35. Rickard D.J., Wang F.L., Rodriguez-Rojas A.M., Wu Z., Trice W.J., Hoffman S.J., Votta B., Stroup G.B., Kumar S., Nuttall M.E. Intermittent treatment with parathyroid hormone (PTH) as well as a non-peptide small molecule agonist of the PTH1 receptor inhibits adipocyte differentiation in human bone marrow stromal cells. Bone 2006, 39:1361-1372.
36. Rodríguez J.P., Garat S., Gajardo H., Pino A.M., Seitz G. Abnormal osteogenesis in osteoporotic patients is reflected by altered mesenchymal stem cells dynamics. J. Cell. Biochem. 1999, 75:414-423.
37. Seals D.R., Bell C. Chronic sympathetic activation: consequence and cause of age-associated obesity?. Diabetes 2004, 53:275-284.
38. Takahada Y., Takarada T., Iemata M., Yamamoto T., Nakamura Y., Kodama A., Yoneda Y. Functional expression of β2 adrenergic receptors responsible for protection against oxidative stress through promotion of glutathione synthesis after Nrf2 upregulation in undifferentiated mesenchymal C3H10T1/2 stem cells. J. Cell. Physiol. 2009, 218:268-275.
39. Takeda S., Elefteriou F., Levasseur R., Liu X., Zhao L., Parker K.L., Armstrong D., Ducy P., Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 2002, 111:305-317.
40. Zhou H., Yang X., Wang N.L., Zhang Y.O., Cai G.P. Tigogenin inhibits adipocytic differentiation and induces osteoblastic differentiation in mouse bone marrow stromal cells. Mol. Cell. Endocrinol. 2007, 270:17-22.
41. Zhou Y.T., Wang Z.W., Higa M., Newgard C.B., Unger R.H. Reversing adipocyte differentiation: implications for treatment of obesity. Proc. Natl. Acad. Sci. U.S.A. 1999, 96:2391-2395.